SUNNYVALE, Calif., Sept. 22, 2016 /PRNewswire/ -- New data on the
Accuray (NASDAQ: ARAY) CyberKnife® and TomoTherapy® Systems will be
shared by leading radiation oncology practitioners, and the
Company's new, innovative radiation therapy treatment delivery
system, the Radixact™ System, and treatment planning software, will
be unveiled at the 2016 ASTRO (American Society for Radiation
Oncology) Annual Meeting in Boston,
Massachusetts, September 25 –
28, 2016. ASTRO is the world's most important meeting for the
radiation oncology community with more than 11,000 attendees each
year. Meeting attendees are invited to attend the U.S. unveiling of
the Radixact System at Accuray booth #2009 on Sunday, September 25 at 11:15 am ET.
The uniquely smart Radixact System, the next generation
TomoTherapy platform, is comprised of three entirely new,
transformative technologies: Radixact Treatment Delivery System,
Accuray Precision™ Treatment Planning System and the iDMS™ Data
Management System. These technologies are now available in the
U.S., where they received FDA 510(k) clearance in June 2016, and in certain markets in the European
Union.
"We are honored to officially introduce the Radixact System to
the U.S. radiation oncology community," said Joshua H. Levine, president and chief executive
officer of Accuray. "This is an exciting time at our company as we
bring to market novel technologies and clinicians present
compelling new data which reinforce the unique benefits of our
technology and have the potential to change the way cancer is
managed."
Meeting highlights and events:
- New clinical evidence: CyberKnife System presentations
include:
- "Five-Year Outcomes from a Multi-Center Trial of Stereotactic
Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer."
GU - Prostate Cancer: Hypofractionation Scientific Session 9.
September 26, 2016. Boston Convention
and Exhibition Center, room number: 210 A/B/C. The session begins
at 7:45 a.m.; the CyberKnife System
presentation starts at 8:15 a.m.
- "Phase I Dose Escalation Trial Using 5-Fraction Stereotactic
Body Radiation Therapy For Partial Breast Irradiation (S-PBI)."
Breast-Toxicity/Altered Fractionation Scientific Session 1.
September 25, 2016. Boston Convention
and Exhibition Center, room number 205 A/B/C. The session begins at
1:15 pm; the CyberKnife System
presentation starts at 2:25 pm.
- New products and work in process:
- Radixact System: equips clinicians with new tools that
enable them to achieve more efficient treatment delivery for a wide
range of patients, including patients undergoing retreatment, and
seamlessly integrates into their department/center.
- Accuray Precision Treatment Planning System: a powerful,
efficient, and comprehensive solution designed to create
high-quality treatment plans leveraging the unique capabilities of
the Radixact and CyberKnife Systems. The Precision System is
available with advanced features including AutoSegmentation™, a
proprietary deformation algorithm, PreciseART™ Adaptive Radiation
Therapy option and PreciseRTX™ Re-treatment option. Demonstrations
will be conducted throughout the meeting.
- Work in progress: treatment planning for Accuray Systems
in RayStation®*, RaySearch's proprietary treatment planning system
(TPS). RayStation is one of the most advanced independent TPS
available, combining unique features such as multi-criteria
optimization tools with full support for 4D adaptive radiation
therapy. The partnership between Accuray and RaySearch will provide
clinicians with access to an integrated treatment planning system
for the precise, innovative Accuray delivery systems and
conventional linear accelerators. Demonstrations will be conducted
throughout the meeting at the Accuray and RaySearch booths. *Not
510k cleared or available for commercial distribution.
- Accuray Exchange in Radiation Oncology (AERO™): AERO
Academy sessions on an extensive range of topics, from prostate
SBRT treatment planning and delivery with the CyberKnife® System
and InCise™ Multileaf Collimator, to efficient planning and
delivery with the TomoTherapy® System. Developed to enable
clinicians to engage in peer-to-peer conversation about optimizing
use of Accuray products, the educational events will be held daily
throughout the meeting. For more information, please visit
Accuray.com/ASTRO2016.
- Educational symposia: A panel of thought leaders will
share their perspectives on how Accuray solutions can help
clinicians deliver precise, innovative tumor treatments with
confidence.
- "Introducing the Radixact™ System: Smart Integration Delivers
Treatment Confidence," on Sunday, September
25, 2016 from 12:15pm –
1:15pm, and;
- "The CyberKnife® System: Confidence in Hypofractionation," on
Monday, September 26, 2016 from
12:30pm – 1:30pm.
For more information about the Accuray symposia, visit:
Accuray.com/ASTRO2016
For more information about the Accuray delivery systems, visit:
Accuray.com
For Important Safety information about radiotherapy please refer
to:
http://www.accuray.com/safety-statement-radiation-treatment.
About Accuray
Accuray Incorporated (NASDAQ: ARAY) is
a radiation oncology company that develops, manufactures and sells
precise, innovative tumor treatment solutions that set the standard
of care with the aim of helping patients live longer, better
lives. The Company's leading-edge technologies deliver the
full range of radiation therapy and radiosurgery treatments.
For more information, please visit www.accuray.com
Safe Harbor Statement
Statements made in this press
release that are not statements of historical fact are
forward-looking statements and are subject to the "safe harbor"
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements in this press release relate, but are
not limited, to clinical applications, clinical results, patient
outcomes, the impact of Accuray's new technologies, the expected
outcome and impact of Accuray's business relationship with
RaySearch, and Accuray's leadership position in radiation oncology
innovation and technologies. Forward-looking statements are subject
to risks and uncertainties that could cause actual results to
differ materially from expectations, including but not limited to
the risks detailed from time to time under the heading "Risk
Factors" in the company's report on Form 10-K, filed on
August 24, 2016 and the company's
other filings with the SEC.
Forward-looking statements speak only as of the date the
statements are made and are based on information available to the
company at the time those statements are made and/or management's
good faith belief as of that time with respect to future
events. The company assumes no obligation to update
forward-looking statements to reflect actual performance or
results, changes in assumptions or changes in other factors
affecting forward-looking information, except to the extent
required by applicable securities laws. Accordingly,
investors should not put undue reliance on any forward-looking
statements.
Media:
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
Danielle Sullivan
MSLGROUP
+1 (781) 684-6680
Danielle.sullivan@mslgroup.com
Logo - http://photos.prnewswire.com/prnh/20160108/320376LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/accuray-to-unveil-new-technology-at-the-astro-2016-annual-meeting-300332426.html
SOURCE Accuray Incorporated